These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8881768)

  • 1. Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332.
    Ahlborg N; Andersson R; Perlmann P; Berzins K
    Immunology; 1996 Aug; 88(4):630-5. PubMed ID: 8881768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predominance of H-2d- and H-2k-restricted T-cell epitopes in the highly repetitive Plasmodium falciparum antigen Pf332.
    Ahlborg N; Sterky F; Haddad D; Perlmann P; Nygren PA; Andersson R; Berzins K
    Mol Immunol; 1997 Apr; 34(5):379-89. PubMed ID: 9293771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation.
    Ahlborg N; Nardin EH; Perlmann P; Berzins K; Andersson R
    Vaccine; 1998 Jan; 16(1):38-44. PubMed ID: 9607007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum-reactive antibodies which inhibit parasite growth but not cytoadherence.
    Ahlborg N; Iqbal J; Hansson M; Uhlén M; Mattei D; Perlmann P; Stahl S; Berzins K
    Parasite Immunol; 1995 Jul; 17(7):341-52. PubMed ID: 8552406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B- and T-cell responses in congenic mice to repeat sequences of the malaria antigen Pf332: effects of the number of repeats.
    Ahlborg N; Andersson R; Ståhl S; Hansson M; Andersson I; Perlmann P; Berzins K
    Immunol Lett; 1994 May; 40(2):147-55. PubMed ID: 8088872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a synthetic immunogen: use of the natural immunomodulator polytuftsin in malaria vaccines against RESA antigen of Plasmodium falciparum.
    Pawan K; Ivanov BB; Kabilan L; Rao DN
    Vaccine; 1994 Jul; 12(9):819-24. PubMed ID: 7526572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein.
    Munesinghe DY; Clavijo P; Calle MC; Nussenzweig RS; Nardin E
    Eur J Immunol; 1991 Dec; 21(12):3015-20. PubMed ID: 1721025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
    Joshi MB; Gam AA; Boykins RA; Kumar S; Sacci J; Hoffman SL; Nakhasi HL; Kenney RT
    Infect Immun; 2001 Aug; 69(8):4884-90. PubMed ID: 11447164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential antibody responses to Plasmodium falciparum-derived B-cell epitopes induced by diepitope multiple antigen peptides (MAP) containing different T-cell epitopes.
    Vasconcelos NM; Siddique AB; Ahlborg N; Berzins K
    Vaccine; 2004 Dec; 23(3):343-52. PubMed ID: 15530679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes.
    Del Giudice G; Tougne C; Louis JA; Lambert PH; Bianchi E; Bonelli F; Chiappinelli L; Pessi A
    Eur J Immunol; 1990 Jul; 20(7):1619-22. PubMed ID: 2201549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii.
    Grillot D; Michel M; Müller I; Tougne C; Rènia L; Mazier D; Corradin G; Lambert PH; Louis JA; Del Guidice G
    Eur J Immunol; 1990 Jun; 20(6):1215-22. PubMed ID: 1695152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
    J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens.
    Chatterjee S; Sharma P; Kumar S; Chauhan VS
    Vaccine; 1995; 13(15):1474-81. PubMed ID: 8578829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
    Koski GK; Ploton IN; Viscidi R; Kumar N
    Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.
    Del Giudice G; Cheng Q; Mazier D; Berbiguier N; Cooper JA; Engers HD; Chizzolini C; Verdini AS; Bonelli F; Pessi A
    Immunology; 1988 Feb; 63(2):187-91. PubMed ID: 2450833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic restriction and specificity of the immune response in mice to fusion proteins containing repeated sequences of the Plasmodium falciparum antigen Pf155/RESA.
    Sjölander A; Andersson R; Hansson M; Berzins K; Perlmann P
    Immunology; 1995 Mar; 84(3):360-6. PubMed ID: 7751017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.
    Calvo-Calle JM; de Oliveira GA; Clavijo P; Maracic M; Tam JP; Lu YA; Nardin EH; Nussenzweig RS; Cochrane AH
    J Immunol; 1993 Feb; 150(4):1403-12. PubMed ID: 7679427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
    Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
    Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.